In addition, both CD4+ and CD8+ T cells in rejecting tumors had higher HLA-DR and PD-1 expression than in concomitant spleens (Fig. 4b), indicating greater T-cell activation in the tumor infiltrate. The gene discussed is CD8A; the disease is neoplasm.